These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32546304)

  • 21. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
    Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
    Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
    [No Abstract]   [Full Text] [Related]  

  • 22. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
    N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
    Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
    BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A
    Pess GM; Sundbom M; Wilson K; Lindqvist D; Dahlin LB
    J Plast Surg Hand Surg; 2018 Oct; 52(5):301-306. PubMed ID: 30039732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Collagenase Treatment for Dupuytren Disease.
    Badalamente MA; Hurst LC
    Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of collagenase clostridium histolyticum for Dupuytren disease nodules: a randomized controlled trial.
    Costas B; Coleman S; Kaufman G; James R; Cohen B; Gaston RG
    BMC Musculoskelet Disord; 2017 Aug; 18(1):374. PubMed ID: 28854973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collagenase Treatment for Dupuytren Disease of the Thumb and First Web.
    Dreise MM; Stenekes MW; Werker PM
    J Hand Surg Am; 2016 Mar; 41(3):348-53.e1. PubMed ID: 26803569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes Following Repeat Collagenase Treatment of Dupuytren Contracture.
    Legato JM; Gill MK; Coutelle NA; Nydick JA
    J Hand Surg Am; 2023 May; ():. PubMed ID: 37256248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Effects of Skin Tearing on Outcomes After Collagenase Treatment of Dupuytren Contractures.
    Zhang D; Blazar P; Benavent KA; Earp BE
    Hand (N Y); 2021 Nov; 16(6):792-796. PubMed ID: 31941375
    [No Abstract]   [Full Text] [Related]  

  • 30. The risk of skin tear in Dupuytren's disease when treated with collagenase.
    Fagernæs C; Mallet S
    Dan Med J; 2018 May; 65(5):. PubMed ID: 29726315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injectable Collagenase Versus Percutaneous Needle Fasciotomy for Dupuytren Contracture in Proximal Interphalangeal Joints: A Randomized Controlled Trial.
    Skov ST; Bisgaard T; Søndergaard P; Lange J
    J Hand Surg Am; 2017 May; 42(5):321-328.e3. PubMed ID: 28473158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.
    Alberton F; Corain M; Garofano A; Pangallo L; Valore A; Zanella V; Adani R
    Musculoskelet Surg; 2014 Dec; 98(3):225-32. PubMed ID: 24254968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited Fasciectomy Versus Collagenase Clostridium histolyticum for Dupuytren Contracture: A Propensity Score Matched Study of Single Digit Treatment With Minimum 5 Years of Telephone Follow-Up.
    Gruber JS; Zhang D; Janssen SJ; Blazar P; Jupiter JB; Earp BE
    J Hand Surg Am; 2021 Oct; 46(10):888-895. PubMed ID: 34275684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagenase clostridium histolyticum injection for the treatment of Dupuytren's contracture.
    Kaplan FT
    Drugs Today (Barc); 2011 Sep; 47(9):653-67. PubMed ID: 21971540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Tongue Depressors as a Technique to Aid Cord Localization During Collagenase Injection For Dupuytren Disease.
    Mehdi SK; Yonz MC; Keshtvarz S; Kamineni S; Dhawan V
    Tech Hand Up Extrem Surg; 2019 Dec; 23(4):196-198. PubMed ID: 31738740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren's disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum.
    Hayton MJ; Bayat A; Chapman DS; Gerber RA; Szczypa PP
    Clin Drug Investig; 2013 Dec; 33(12):905-12. PubMed ID: 24092562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage palmar fasciectomy after initial treatment with collagenase clostridium histolyticum.
    Eberlin KR; Kobraei EM; Nyame TT; Bloom JM; Upton J
    Plast Reconstr Surg; 2015 Jun; 135(6):1000e-1006e. PubMed ID: 26017606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
    McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
    Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture.
    Raven RB; Kushner H; Nguyen D; Naam N; Curtin C
    Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic dermatitis secondary to treatment with collagenase clostridium histolyticum for Dupuytren´s disease.
    Sanjuan-Cervero R; Poquet-Jornet JE; Carrera-Hueso FJ
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3688-91. PubMed ID: 27649672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.